Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993-2003 by Wilson, D. et al.
 PUBLISHED VERSION  
 
 
Wilson, David Hugh Dunlop; Tucker, Graeme Riland; Frith, Peter A.; Appleton, Sarah 
Louise; Ruffin, Richard Ernest; Adams, Robert John  
Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary 
disease in Australia, 1993-2003 Medical Journal of Australia, 2007; 186(8):408-411 
 



























This document has been archived with permission from the editor of the Medical 




RESEARCHTrends in hospital admissions and mortality from asthma and 
chronic obstructive pulmonary disease in Australia, 1993–2003
David H Wilson, Graeme Tucker, Peter Frith, Sarah Appleton, Richard E Ruffin and Robert J AdamsThe Medical Journal of Australia ISSN:
0025-729X 16 April 2007 186 8 408-411
©The Medical Journal of Australia 2007
www.mja.com.au
Research
cause of death in Australia, just behind
cancer,6 is comparatively neglected as a
health priority in terms of policy and inter-
ventions to support education and manage-
ment. A thma has also commanded a major
intervention focus in general practice








Objective:  To examine evolving changes in asthma and chronic obstructive pulmonary 
disease (COPD) in South Australia and Australia as a whole from the perspective of 
hospital admissions, ventilatory support and mortality data.
Design:  Retrospective analyses, for the period 1993–2003, of hospital separations data 
from the Australian Institute of Health and Welfare and the Integrated South Australian 
ity Collection, and mortality data from the Australian Bureau of Statistics and South 
alian hospital morbidity collection.
 outcome measures:  Hospital separations, ventilatory support episodes, mortality 
, burden-of-disease rankings.
lts:  Between 1993 and 2003, in SA and nationally, hospital separations for asthma 
ned but separations for COPD increased significantly. Falling mortality rates from 
a in both men and women, and from COPD in men, contrast with increasing rates 
of COPD-related hospitalisation and mortality in women.
Conclusions:  Hospital admissions and mortality associated with asthma have fallen. 
Admission rates for COPD are declining for men, but there is no indication that 
admission rates for women have reached a peak. There is a need for higher prioritisation 
of COPD, including policies to reduce smoking in women, and medical practice 
initiatives to support primary and secondary prevention, pulmonary rehabilitation and 
MJA 2007; 186: 408–411
appropriate drug therapies.nu
tre
of A mber of studies have identified and towards increasing prevalenceboth asthma1,2 and chronic
obstructive pulmonary disease (COPD) in
recent years.3-5 Asthma has been declared a
national priority area, but COPD, which is
reported to be the fourth most important
ing more management time through
extended consultations for at-risk asthma
patients7 — but no such attention has been
given to COPD.8 This is despite the fact that
both conditions have long-term impacts and
costs,5 together account for the bulk of
chronic respiratory disease, and have been
the subject of comprehensive international
guidelines and discussion.
In this article we examine the comparative
impact and changing nature of both asthma
and COPD from the perspective of hospital
admissions, management data and mortality
trends over the period 1993–2003. The
changing pattern of each condition is exam-
ined in South Australia and compared with
Australia as a whole.
METHODS
Our data sources for hospital admissions for
asthma and COPD for the financial years
1993–04 to 2003–04 were:
• the Australian Institute of Health and
Welfare (AIHW) website,9 for Australia as a
whole; and
• the Integrated South Australian Activity
Collection (ISAAC) inpatient separations
database, for SA (unpublished data).
Diagnoses of asthma or COPD were deter-
mined based on the principal International
classification of diseases (10th revision)
(ICD-10) diagnosis code. Secondary diag-
noses were not considered.
For the SA data only, we determined
whether a patient had received ventilation
support by intubation or ventilation in an
intensive care unit on the basis of all proce-
dures coded for asthma and COPD. The same
analysis could not be done with national
data, as the AIHW website gives this informa-
tion for all combined conditions but not
asthma and COPD separately. Separations for
people aged under 15 years were excluded, to
focus on adult asthma and COPD.
Mortality data for Australia and SA were
obtained from the Australian Bureau of Sta-
tistics for the period 1993–2003 (unpub-
lished data).
National data on the burden-of-disease
ranking of asthma and COPD (in terms of
years lost to disability) were obtained from
the AIHW.10 Equivalent SA data were
obtained from an SA government report.11
Statistical methods
The data analysed were time series, but the
series were not long enough to use estab-
lished time series techniques in assessing
trend. The models used in our analyses
tested for a linear relationship between the
age- and sex-standardised rate of separations
per 100 000 population and time. This was
done by fitting a simple linear regression of
the series against the year and examining
whether the coefficient of year was statisti-
cally significant at the 5% level. Our model
used the calculation of robust estimators of
standard errors (SEs) provided by Stata soft-
ware, release 9 (StataCorp, College Station,
Tex, USA). The Huber–White sandwich
robust variance estimator produces consist-
ent SEs for ordinary least squares regression
coefficient estimates in the presence of het-
eroskedasticity (ie, unequal variance in the
regression errors).
As the data were time series, it was possi-
ble that they were auto-correlated. Accord-
ingly, errors in the regression model were
tested for auto-correlation using the alterna-
tive Durbin–Watson test for first-order serial
correlation in the disturbance. Where auto-
correlation in the errors was detected, the
model was refit using the Newey–West vari-
ance estimator, which handles auto-correla-
tion up to and including a specified lag, as
well as the presence of heteroskedasticity.
The Newey–West model produced variance
estimates that were exactly the Huber–
White sandwich robust variance estimates
calculated by the robust regression estimator
(above) when no lag was included in the
model. Thus, the two models used to assess
linear trend were entirely consistent. Only
first-order correlation was allowed for in the
fitting of the models.MJA • Volume 186 Number 8 • 16 April 2007
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Trends in hospital separations for asthma
and COPD per 100 000 population per year
in Australia and in SA over the period
studied are summarised in Box 1. Nationally
and in SA, for both men and women overall,
there was a strong downward trend in hos-
pital admissions for asthma per 100 000
population. At a national level, the down-
ward trend was also seen in each separate
age group (except men aged 15–34),
whereas at state level, the downward trend
was seen only among men and women aged
 55 and women aged 15–34. The largest
annual decline in adult admission rates for
asthma at both the national and state levels
was found in men and women aged  55
years.
In contrast, there was a strong upward
trend nationally in separations for COPD
per 100 000 population, for men and
women overall and for both sexes individu-
ally, in age groups 35–54 years and  55
years. This contrasts with SA rates, which
showed a significant increase for women
overall and in the two older age groups but
no significant change for men in any age
group.
There was a statistically significant fall in
asthma patient bed days per 100 000 popu-
lation per year at both national level (all
persons, –89.34 days; P < 0.001) and state
level (all persons, –67.23 days; P < 0.001).
By comparison, there was a significant
increase in COPD patient bed days at the
national level (all persons, +41.46 days; P =
0.031) but not at the state level (all persons,
–84.63 days, P = 0.111).
In SA, there was a small but significant
increase in age- and sex-standardised venti-
lation rates for asthma per 100 000 popula-
tion over the study period (all persons,
+0.09 ventilations/year per 100 000 popula-
tion; P = 0.014). Ventilation rates for COPD
per 100 000 population increased overall
(+0.96; P < 0.001), with the highest
increases being in the  55-years age group
in both men (+5.61; P < 0.001) and women
(+5.52; P < 0.001). Ventilation rates also
increased significantly among women aged
35–54 years (+0.68; P = 0.003).
Trends in mortality rates for asthma and
COPD over the period studied are shown in
Box 2. There was a significant fall in deaths
due to asthma at both national and state
levels in both men and women. Nationally,
the decline was apparent in every age group
for both sexes. However, a different picture
emerges for COPD. There was a significant
fall in COPD mortality overall for men at
both the national level (–2.98 events/year
per 100 000 population; P < 0.001) and state
level (–2.64 events/year per 100 000 popu-
2 Comparison of trends (events per year) in mortality for asthma and chronic obstructive pulmonary disease (COPD) 
per 100 000 population, Australia and South Australia, 1993–04 to 2003–04, by age and sex
Deaths from asthma Deaths from COPD
Australia P SA P Australia P SA P
All persons (ASR) –0.53 < 0.001 –0.49 < 0.001 –1.65 < 0.001 –1.33 0.001
Males (ASR) –0.45 < 0.001 –0.51 0.003 –2.98 < 0.001 –2.64 < 0.001
Males 15–34 years –0.04 0.006 –0.06 0.131 0.00 0.582 0.02 0.454
Males 35–54 years –0.12 < 0.001 –0.20 0.041 –0.06 0.008 0.12 0.132
Males  55 years –1.18 < 0.001 –1.37 0.004 –7.04 < 0.001 –7.06 0.001
Females (ASR) –0.60 < 0.001 –0.46 0.005 –0.37 0.068 –0.07 0.635
Females 15–34 years –0.06 0.009 0.03 0.452 0.00 0.848 0.00 0.902
Females 35–54 years –0.11 < 0.001 0.12 0.311 –0.01 0.513 0.09 0.436
Females  55 years –1.12 < 0.001 –1.40 0.002 0.18 0.725 0.10 0.905
ASR = age-standardised rate. ◆
1 Comparison of trends (events per year) in separations for asthma and chronic obstructive pulmonary disease (COPD) 
per 100 000 population, Australia and South Australia, 1993–04 to 2003–04, by age and sex
Asthma separations COPD separations
Australia P SA P Australia P SA P
All persons (ASR) –12.13 < 0.001 –7.23 0.001 13.75 < 0.001 2.78 0.281
Males (ASR) –9.56 < 0.001 –4.55 0.003 11.40 0.002 –0.50 0.891
Males 15–34 years –3.29 0.063 –2.40 0.284 –0.06 0.369 –0.16 0.718
Males 35–54 years –3.07 < 0.001 –1.12 0.224 2.13 0.005 1.16 0.299
Males  55 years –25.56 < 0.001 –10.64 < 0.001 37.28 0.002 0.14 0.989
Females (ASR) –14.61 < 0.001 –9.80 0.001 16.00 < 0.001 5.92 0.004
Females 15–34 years –9.72 < 0.001 –13.13 < 0.001 –0.22 0.115 –1.07 0.042
Females 35–54 years –7.52 < 0.001 –2.49 0.372 3.27 < 0.001 2.89 0.014
Females  55 years –27.41 < 0.001 –13.21 < 0.001 46.34 < 0.001 15.72 0.005
ASR = age-standardised rate.  ◆MJA • Volume 186 Number 8 • 16 April 2007 409
RESEARCHlation; P < 0.001). However, there was no
significant decline among women at either
national or state level. There were also no
age-specific changes in mortality rates for
women per 100 000 population at national
or state levels.
The trends in COPD mortality rates for
men and women have been converging
since the beginning of the series (Box 3).
This phenomenon is much less pronounced
for asthma, especially since 1998 (Box 4).
Burden-of-disease rankings for asthma
and COPD for Australia and SA are summa-
rised in Box 5. Overall, in burden-of-disease
terms, both asthma and COPD are ranked
higher at the national level than at the state
level. COPD is ranked higher than asthma at
both national and state levels.
DISCUSSION
We have shown that declining mortality rates
for asthma and COPD in men contrast with
increasing COPD hospitalisations and mor-
tality in women. The greatest increase in
burden of COPD hospital separations and
deaths in our study was in the 55-years age
group in women, but there have also been
significant increases in admission rates, for
both sexes, in the 35–54-years age group,
and it may be here that the greatest gains can
be made through smoking cessation initia-
tives and better disease management.
Our results reflect similar findings inter-
nationally and provide further evidence of
the expanding global burden of COPD.12
Between 1980 and 2000, deaths from COPD
in the United States more than doubled for
women and remained consistently higher
for men than women.13 The prevalence of
chronic bronchitis in the US has also
increased markedly in women and young
people of both sexes, as has the number of
hospitalisations for this condition, particu-
larly in women.14
As COPD is preventable and treatable, a
strong public health message and funding
commitment are warranted. Given that at
least 60% of the risk of COPD is attributable
to smoking,15 reducing smoking prevalence
is the key to modifying the future burden of
COPD.16 But there are also sound reasons
for promoting earlier diagnosis of COPD.
People with undiagnosed COPD have a
poorer quality of life and functional status
than people with similar lung function who
have been diagnosed with COPD and
received appropriate treatment.17 There are
effective treatments for COPD that improve
outcomes. Treatment with long-acting β-
agonists18 and tiotropium19 improves exer-
cise duration, reduces breathlessness on
exertion, and improves quality of life.20
Inhaled corticosteroids reduce the frequency
and severity of exacerbations and hospitali-
sations,21 and pulmonary rehabilitation
reduces breathlessness.22 For these reasons,
it is of concern that COPD remains undiag-
nosed in many Australians of all ages.23
It has been argued that hospitalisations do
not accurately represent the burden of a
health problem in a community, but, rather,
may reflect the availability of care,5 current
management strategies or changes in prior-
ity-setting. However, the fact that people
hospitalised with COPD have a subse-
quently increased risk of death over 5 years
compared with those not hospitalised sug-
gests the former are an at-risk group.24
The considerable increase in COPD
admissions over asthma is reflected in the
comparative burden-of-disease rankings,
but this is not reflected in the priority given
to COPD in Australia. Given that Australian
COPD mortality rates observed in our study
were 14 times that of asthma in 2003, and
even allowing for some death certificate
misclassification, its priority position needs
to be recognised.
The decline in hospital admissions for
asthma cannot be explained by a fall in
asthma prevalence over this period.2,25
However, it could be argued that cases of
severe asthma are becoming more effectively
managed out of hospital.2
Smoking remains a major public health
issue in both men and women under 40
years of age and in lower socioeconomic
groups.26 In 2004, the overall smoking rate
in people aged 20–40 years was 24% for
men and 22% for women. In people aged
14–19 years, the prevalence was higher for
females (12%) than males (10%).27 As
COPD is increasingly being seen at younger
ages in women, who may be more suscepti-
ble to the disease than men,28 and given that
hospitalisation rates are increasing, there is a
case for targeting health education about
COPD specifically at women. Targeting
women with additional female-specific pro-
grams on smoking and COPD is likely to
have greater impact than generalised smok-
ing cessation programs.
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RESEARCHOur study had a number of limitations.
First, there is no “gold standard” of asthma
diagnosis and the condition is difficult to
diagnose in older people, especially for the
first time. Some cases classified as COPD
may therefore be asthma or have a compo-
nent of asthma. Furthermore, there is clear
evidence that COPD is under-detected and
misdiagnosed as asthma.29,30 The complex-
ity of diagnosis of respiratory problems in
older people means that health professionals
may also misclassify asthma or COPD and
therefore underestimate mortality from
these diseases. However, even if we allowed
for a doubling of asthma mortality, the
problem would still be overwhelmed by the
problem of COPD.
Despite falls in the 1980s and 1990s,
smoking rates have been fairly stable since
the end of the 1990s. If this stable preva-
lence continues, COPD will continue to
carry a high burden of disease. Future
response to COPD needs to occur at both
government and health professional levels.
Prevention and treatment strategies to
reduce the burden of this problem already
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5 Current burden-of-disease rankings (based on years lost to disability) for 
asthma and chronic obstructive pulmonary disease (COPD) in Australia and 
South Australia
Males Females All persons
Asthma Rank in Australia 14 7 9
Rank in SA 15 9 11
Severity weight* 0.058 0.058 —*
COPD Rank in Australia 4 6 3
Rank in SA 4 7 6
Severity weight* 0.168 0.159 —*
* For more detail on severity weight, see Mathers et al.10 As severity weight is sex-specific, none is provided 
for the “all persons” category. ◆MJA • Volume 186 Number 8 • 16 April 2007 411
